Success Metrics

Clinical Success Rate
88.9%

Based on 88 completed trials

Completion Rate
89%(88/99)
Active Trials
3(3%)
Results Posted
35%(31 trials)
Terminated
11(10%)

Phase Distribution

Ph early_phase_1
1
1%
Ph phase_1
11
10%
Ph phase_2
14
13%
Ph phase_4
15
13%
Ph phase_3
43
38%
Ph not_applicable
5
4%

Phase Distribution

12

Early Stage

14

Mid Stage

58

Late Stage

Phase Distribution89 total trials
Early Phase 1First-in-human
1(1.1%)
Phase 1Safety & dosage
11(12.4%)
Phase 2Efficacy & side effects
14(15.7%)
Phase 3Large-scale testing
43(48.3%)
Phase 4Post-market surveillance
15(16.9%)
N/ANon-phased studies
5(5.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.3%

88 of 102 finished

Non-Completion Rate

13.7%

14 ended early

Currently Active

3

trials recruiting

Total Trials

112

all time

Status Distribution
Active(3)
Completed(88)
Terminated(14)
Other(7)

Detailed Status

Completed88
Terminated11
unknown7
Withdrawn3
Active, not recruiting2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
112
Active
3
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (1.1%)
Phase 111 (12.4%)
Phase 214 (15.7%)
Phase 343 (48.3%)
Phase 415 (16.9%)
N/A5 (5.6%)

Trials by Status

withdrawn33%
active_not_recruiting22%
completed8879%
recruiting11%
terminated1110%
unknown76%

Recent Activity

Clinical Trials (112)

Showing 20 of 112 trialsScroll for more
NCT04867317Phase 3

Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)

Recruiting
NCT05690386Phase 2

A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome

Active Not Recruiting
NCT02968004Phase 3

Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Completed
NCT05382637Phase 2

Growth Hormone in a Patient With a Dominant-Negative GHR Mutation

Active Not Recruiting
NCT03554265Phase 3

Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy

Completed
NCT04615273Phase 3

A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency

Completed
NCT01562834Phase 4

Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients

Completed
NCT00163189Phase 3

Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm

Completed
NCT06103513Phase 3

Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children

Unknown
NCT01306357

Evaluation of Overall Compliance and Duration of Zomacton® Treatment With the Zomajet® Needle-free Device

Completed
NCT00705172

Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome

Completed
NCT01897766

Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese"

Completed
NCT01529944Phase 3

Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658

Completed
NCT00840944Phase 4

A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height

Unknown
NCT05900661Phase 2

The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders

Unknown
NCT03123913Phase 1

Study of Testosterone and rHGH in FSHD

Completed
NCT03038594Phase 2

Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients

Completed
NCT03435627

Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)

Completed
NCT01578135

French National Registry of Children Born Small for Gestational Age Treated With Somatropin

Completed
NCT02726542Early Phase 1

Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents

Completed

Drug Details

Intervention Type
DRUG
Total Trials
112